BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

被引:61
作者
Gorski, Julia J. [1 ]
James, Colin R. [1 ]
Quinn, Jennifer E. [1 ]
Stewart, Gail E. [1 ]
Staunton, Kieran Crosbie [1 ]
Buckley, Niamh E. [1 ]
McDyer, Fionnuala A. [2 ]
Kennedy, Richard D. [2 ]
Wilson, Richard H. [1 ]
Mullan, Paul B. [1 ]
Harkin, D. Paul [1 ]
机构
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Dept Oncol, Belfast BT9 7BL, Antrim, North Ireland
[2] Almac Diagnost, Craigavon BT63 5QD, North Ireland
基金
英国医学研究理事会;
关键词
BRCA1; Breast cancer; Basal-like phenotype; Transcription; C-MYC; EPITHELIAL PHENOTYPE; ESTROGEN-RECEPTOR; CELL-LINES; TUMORS; MUTATIONS; SUBTYPES;
D O I
10.1007/s10549-009-0565-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression profiling of BRCA1-deficient tumours has identified a pattern of gene expression similar to basal-like breast tumours. In this study, we examine whether a BRCA1-dependent transcriptional mechanism may underpin the link between BRCA1 and basal-like phenotype. In methods section, the mRNA and protein were harvested from a number of BRCA1 mutant and wild-type breast cancer cell lines and from matched isogenic controls. Microarray-based expression profiling was used to identify potential BRCA1-regulated transcripts. These gene targets were then validated (by in silico analysis of tumour samples) by real-time PCR and Western blot analysis. Chromatin immunoprecipitation (ChIP) assays were used to confirm recruitment of BRCA1 to specific promoters. In results, we demonstrate that functional BRCA1 represses the expression of cytokeratins 5(KRT5) and 17(KRT17) and p-Cadherin (CDH3) in HCC1937 and T47D breast cancer cell lines at both mRNA and protein level. ChIP assays demonstrate that BRCA1 is recruited to the promoters of KRT5, KRT17 and CDH3, and re-ChIP assays confirm that BRCA1 is recruited independently to form c-Myc and Sp1 complexes on the CDH3 promoter. We show that siRNA-mediated inhibition of endogenous c-Myc (and not Sp1) results in a marked increase in CDH3 expression analogous to that observed following the inhibition of endogenous BRCA1. The data provided suggest a model whereby BRCA1 and c-Myc form a repressor complex on the promoters of specific basal genes and represent a potential mechanism to explain the observed overexpression of key basal markers in BRCA1-deficient tumours.
引用
收藏
页码:721 / 731
页数:11
相关论文
共 25 条
[1]   BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene [J].
Abramovitch, S ;
Glaser, T ;
Ouchi, T ;
Werner, H .
FEBS LETTERS, 2003, 541 (1-3) :149-154
[2]   Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer [J].
Arnes, JB ;
Brunet, JS ;
Stefansson, I ;
Bégin, LR ;
Wong, N ;
Chappuis, PO ;
Akslen, LA ;
Foulkes, WD .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4003-4011
[3]   BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants [J].
Elstrodt, F ;
Hollestelle, A ;
Nagel, JHA ;
Gorin, M ;
Wasielewski, M ;
van den Ouweland, A ;
Merajver, SD ;
Ethier, SP ;
Schutte, M .
CANCER RESEARCH, 2006, 66 (01) :41-45
[4]   The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer [J].
Foulkes, WD ;
Brunet, JS ;
Stefansson, IM ;
Straume, O ;
Chappuis, PO ;
Bégin, LR ;
Hamel, N ;
Goffin, JR ;
Wong, N ;
Trudel, M ;
Kapusta, L ;
Porter, P ;
Akslen, LA .
CANCER RESEARCH, 2004, 64 (03) :830-835
[5]   Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer [J].
Foulkes, WD ;
Stefansson, IM ;
Chappuis, PO ;
Bégin, LR ;
Goffin, JR ;
Wong, N ;
Trudel, M ;
Akslen, LA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19) :1482-1485
[6]   Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome [J].
Foulkes, WD ;
Chappuis, PO ;
Wong, N ;
Brunet, JS ;
Vesprini, D ;
Rozen, F ;
Yuan, ZQ ;
Pollak, MN ;
Kuperstein, G ;
Narod, SA ;
Bégin, LR .
ANNALS OF ONCOLOGY, 2000, 11 (03) :307-313
[7]   MYC is amplified in BRCA1-associated breast cancers [J].
Grushko, TA ;
Dignam, JJ ;
Das, S ;
Blackwood, AM ;
Perou, CM ;
Ridderstråle, KK ;
Anderson, KN ;
Wei, MJ ;
Adams, AJ ;
Hagos, FG ;
Sveen, L ;
Lynch, HT ;
Weber, BL ;
Olopade, OI .
CLINICAL CANCER RESEARCH, 2004, 10 (02) :499-507
[8]   Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer [J].
Hosey, Alison M. ;
Gorski, Julia J. ;
Murray, Margaret M. ;
Quinn, Jennifer E. ;
Chung, Wen Y. ;
Stewart, Gail E. ;
James, Colin R. ;
Farragher, Susan M. ;
Mulligan, Jude M. ;
Scott, Alistair N. ;
Dervan, Peter A. ;
Johnston, Patrick G. ;
Couch, Fergus J. ;
Daly, Peter A. ;
Kay, Elaine ;
McCann, Amanda ;
Mullan, Paul B. ;
Harkin, D. Paul .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (22) :1683-1694
[9]   BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene [J].
Kennedy, RD ;
Gorski, JJ ;
Quinn, JE ;
Stewart, GE ;
James, CR ;
Moore, S ;
Mulligan, K ;
Emberley, ED ;
Lioe, TF ;
Morrison, PJ ;
Mullan, PB ;
Reid, G ;
Johnston, PG ;
Watson, PH ;
Harkin, DP .
CANCER RESEARCH, 2005, 65 (22) :10265-10272
[10]   Cytokeratin 5/14-positive breast cancer:: true basal phenotype confined to BRCA1 tumors [J].
Laakso, M ;
Loman, N ;
Borg, Å ;
Isola, J .
MODERN PATHOLOGY, 2005, 18 (10) :1321-1328